Semiconductors
Compare Stocks
2 / 10Stock Comparison
TRT vs ACLS
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
TRT vs ACLS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Semiconductors | Semiconductors |
| Market Cap | $101M | $4.88B |
| Revenue (TTM) | $49M | $845M |
| Net Income (TTM) | $-109K | $101M |
| Gross Margin | 19.7% | 43.6% |
| Operating Margin | 0.5% | 11.6% |
| Forward P/E | — | 43.5x |
| Total Debt | $2M | $42M |
| Cash & Equiv. | $11M | $145M |
TRT vs ACLS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Trio-Tech Internati… (TRT) | 100 | 408.5 | +308.5% |
| Axcelis Technologie… (ACLS) | 100 | 590.9 | +490.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TRT vs ACLS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TRT is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.52
- Rev growth -13.8%, EPS growth -104.0%, 3Y rev CAGR -6.1%
- Lower volatility, beta 0.52, Low D/E 5.1%, current ratio 5.03x
ACLS carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 15.1% 10Y total return vs TRT's 248.3%
- 11.9% margin vs TRT's -0.2%
- +173.2% vs TRT's +121.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -13.8% revenue growth vs ACLS's -17.6% | |
| Quality / Margins | 11.9% margin vs TRT's -0.2% | |
| Stability / Safety | Beta 0.52 vs ACLS's 2.00 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +173.2% vs TRT's +121.8% | |
| Efficiency (ROA) | 7.5% ROA vs TRT's -0.2%, ROIC 9.6% vs 0.8% |
TRT vs ACLS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TRT vs ACLS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ACLS leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACLS is the larger business by revenue, generating $845M annually — 17.2x TRT's $49M. ACLS is the more profitable business, keeping 11.9% of every revenue dollar as net income compared to TRT's -0.2%. On growth, TRT holds the edge at +81.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $49M | $845M |
| EBITDAEarnings before interest/tax | $3M | $111M |
| Net IncomeAfter-tax profit | -$109,000 | $101M |
| Free Cash FlowCash after capex | $137,000 | $90M |
| Gross MarginGross profit ÷ Revenue | +19.7% | +43.6% |
| Operating MarginEBIT ÷ Revenue | +0.5% | +11.6% |
| Net MarginNet income ÷ Revenue | -0.2% | +11.9% |
| FCF MarginFCF ÷ Revenue | +0.3% | +10.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +81.6% | +3.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -76.0% | -65.9% |
Valuation Metrics
TRT leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, TRT's 30.8x EV/EBITDA is more attractive than ACLS's 34.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $101M | $4.9B |
| Enterprise ValueMkt cap + debt − cash | $92M | $4.8B |
| Trailing P/EPrice ÷ TTM EPS | -2416.67x | 41.75x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 43.49x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.98x |
| EV / EBITDAEnterprise value multiple | 30.78x | 34.85x |
| Price / SalesMarket cap ÷ Revenue | 2.78x | 5.81x |
| Price / BookPrice ÷ Book value/share | 2.98x | 4.86x |
| Price / FCFMarket cap ÷ FCF | — | 45.56x |
Profitability & Efficiency
ACLS leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
ACLS delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-0 for TRT. ACLS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to TRT's 0.05x. On the Piotroski fundamental quality scale (0–9), ACLS scores 5/9 vs TRT's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -0.3% | +9.8% |
| ROA (TTM)Return on assets | -0.2% | +7.5% |
| ROICReturn on invested capital | +0.8% | +9.6% |
| ROCEReturn on capital employed | +0.7% | +10.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.05x | 0.04x |
| Net DebtTotal debt minus cash | -$9M | -$103M |
| Cash & Equiv.Liquid assets | $11M | $145M |
| Total DebtShort + long-term debt | $2M | $42M |
| Interest CoverageEBIT ÷ Interest expense | 0.57x | 77.10x |
Total Returns (Dividends Reinvested)
ACLS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACLS five years ago would be worth $38,679 today (with dividends reinvested), compared to $22,481 for TRT. Over the past 12 months, ACLS leads with a +173.2% total return vs TRT's +121.8%. The 3-year compound annual growth rate (CAGR) favors TRT at 39.2% vs ACLS's 9.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -6.8% | +84.2% |
| 1-Year ReturnPast 12 months | +121.8% | +173.2% |
| 3-Year ReturnCumulative with dividends | +169.5% | +32.2% |
| 5-Year ReturnCumulative with dividends | +124.8% | +286.8% |
| 10-Year ReturnCumulative with dividends | +248.3% | +1505.9% |
| CAGR (3Y)Annualised 3-year return | +39.2% | +9.7% |
Risk & Volatility
Evenly matched — TRT and ACLS each lead in 1 of 2 comparable metrics.
Risk & Volatility
TRT is the less volatile stock with a 0.52 beta — it tends to amplify market swings less than ACLS's 2.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACLS currently trades 92.5% from its 52-week high vs TRT's 60.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.52x | 2.00x |
| 52-Week HighHighest price in past year | $19.10 | $171.60 |
| 52-Week LowLowest price in past year | $4.42 | $55.81 |
| % of 52W HighCurrent price vs 52-week peak | +60.7% | +92.5% |
| RSI (14)Momentum oscillator 0–100 | 58.4 | 84.4 |
| Avg Volume (50D)Average daily shares traded | 1.0M | 734K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $128.00 |
| # AnalystsCovering analysts | — | 12 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.5% |
ACLS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TRT leads in 1 (Valuation Metrics). 1 tied.
TRT vs ACLS: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is TRT or ACLS a better buy right now?
For growth investors, Trio-Tech International (TRT) is the stronger pick with -13.
8% revenue growth year-over-year, versus -17. 6% for Axcelis Technologies, Inc. (ACLS). Axcelis Technologies, Inc. (ACLS) offers the better valuation at 41. 8x trailing P/E (43. 5x forward), making it the more compelling value choice. Analysts rate Axcelis Technologies, Inc. (ACLS) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — TRT or ACLS?
Over the past 5 years, Axcelis Technologies, Inc.
(ACLS) delivered a total return of +286. 8%, compared to +124. 8% for Trio-Tech International (TRT). Over 10 years, the gap is even starker: ACLS returned +1506% versus TRT's +248. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — TRT or ACLS?
By beta (market sensitivity over 5 years), Trio-Tech International (TRT) is the lower-risk stock at 0.
52β versus Axcelis Technologies, Inc. 's 2. 00β — meaning ACLS is approximately 282% more volatile than TRT relative to the S&P 500. On balance sheet safety, Axcelis Technologies, Inc. (ACLS) carries a lower debt/equity ratio of 4% versus 5% for Trio-Tech International — giving it more financial flexibility in a downturn.
04Which is growing faster — TRT or ACLS?
By revenue growth (latest reported year), Trio-Tech International (TRT) is pulling ahead at -13.
8% versus -17. 6% for Axcelis Technologies, Inc. (ACLS). On earnings-per-share growth, the picture is similar: Axcelis Technologies, Inc. grew EPS -38. 2% year-over-year, compared to -104. 0% for Trio-Tech International. Over a 3-year CAGR, ACLS leads at -3. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — TRT or ACLS?
Axcelis Technologies, Inc.
(ACLS) is the more profitable company, earning 14. 3% net margin versus -0. 1% for Trio-Tech International — meaning it keeps 14. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACLS leads at 14. 2% versus 0. 7% for TRT. At the gross margin level — before operating expenses — ACLS leads at 44. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — TRT or ACLS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is TRT or ACLS better for a retirement portfolio?
For long-horizon retirement investors, Trio-Tech International (TRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
52), +248. 3% 10Y return). Axcelis Technologies, Inc. (ACLS) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TRT: +248. 3%, ACLS: +1506%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between TRT and ACLS?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.